Sen. Josh Hawley (R-MO) said Friday that he believes Food and Drug Administration Commissioner Marty Makary “misled” him regarding his commitment to President Donald Trump’s anti-abortion agenda after the agency approved a new generic version of an abortion pill .

Hawley was one of the first senators on Thursday to criticize the FDA for approving the new generic version of the pill mifepristone, which will be produced by the company Evita Solutions . He said he has “lost confidence” in the agency.

Recommended Stories

Fact check: Healthcare for illegal immigrants and the government shutdown

Trump FDA approves new generic abortion pill, angering conservatives

CDC awards contract to RPI to study link between vaccines and autism

Both Makary and Health and Human Services Secreta

See Full Page